-+ 0.00%
-+ 0.00%
-+ 0.00%

Ascentage Pharma Wins FDA and EMA Clearance for Global Phase III Study of Olverembatinib in Ph+ ALL

Reuters·12/04/2025 23:57:22

Please log in to view news